 |
Cohort profile: the Hunter Community Study |
McEvoy, Mark; Smith, Wayne; Hancock, Stephen; Smith, Derek; Attia, John... More
|
2010 |
—
|
|
 |
Does it matter who writes medical news stories? |
Wilson, Amanda; Robertson, Jane; McElduff, Patrick; Jones, Alison; Henry, David |
2010 |
|
|
 |
The efficiency frontier approach to economic evaluation of health-care interventions |
Caro, J. Jaime; Nord, Erik; Siebert, Uwe; McGuire, Alistair; McGregor, Maurice... More
|
2010 |
—
|
|
 |
Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department |
Lee, Douglas S.; Stukel, Therese A.; Austin, Peter C.; Alter, David A.; Schull, Michael J.... More
|
2010 |
—
|
|
 |
Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme |
Robertson, Jane; Walkom, Emily; Moynihan, Ray; Bero, Lisa; Henry, David |
2010 |
—
|
|
 |
Mandatory disclosure of pharmaceutical industry-funded events for health professionals |
Robertson, Jane; Moynihan, Ray; Walkom, Emily; Bero, Lisa; Henry, David |
2009 |
|
|
 |
Media reporting of health interventions: signs of improvement, but major problems persist |
Wilson, Amanda; Bonevski, Billie; Jones, Alison; Henry, David |
2009 |
—
|
|
 |
Medicine in the news |
Wilson, Amanda; Kirkwood, Ian; Henry, David; Jones, Alison |
2009 |
—
|
|
 |
The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis |
Henry, David; Carless, Paul; Fergusson, Dean; Laupacis, Andreas |
2009 |
—
|
|
 |
Australian pharmaceutical policy and the idea of innovation |
Doran, Evan; Henry, David; Faunce, Thomas A.; Searles, Andrew |
2008 |
|
|
 |
Australian pharmaceutical policy: price control, equity, and drug innovation in Australia |
Doran, Evan; Henry, David; Fauce, Thomas A.; Searles, Andrew |
2008 |
—
|
|
 |
Disease mongering is now part of the global health debate |
Moynihan, Ray; Doran, Evan; Henry, David |
2008 |
|
|
 |
Ensuring the safety of new medications and devices: are naltrexone implants safe? (editorial) |
Wodak, Alex D.; Ali, Robert; Henry, David; Sansom, Lloyd |
2008 |
—
|
|
 |
Selective COX-2 inhibitors, NSAID's and congestive heart failure: differences between new and recurrent cases |
McGettigan, Patricia; Han, Pearline; Jones, Lisa; Whitaker, Diana; Henry, David |
2008 |
—
|
|
 |
What drives health-care spending priorities?: an international survey of health-care professionals |
Salkeld, Glenn; Henry, David; Hill, Suzanne; Lang, Danielle; Freemantle, Nick... More
|
2007 |
—
|
|